Picture Kentro Design Corporate and Web Design for Start Ups 650x80px

Organisation › Details

Bristol-Myers Squibb Co. (BMS) (NYSE: BMY)

https://www.bms.com

LinkedIn: https://www.linkedin.com/company/bristol-myers-squibb

Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life. *

	Start	1989-10-04 merged
	Group	Bristol-Myers Squibb (BMS) (Group)
	Industry	pharmaceutical

	Region	New York, NY
	Country	United States (USA)
	Street	430 East 29th Street 14th Floor
	City	10016 New York, NY
	Tel	+1-212-546-4000
		Address record changed: 2020-12-02

Basic data	Employees	H: 10,001 to 50,00 (2018-12-31)
	Currency	USD
	Annual sales	22,561,000,000 (revenue, total, consolidated (2018) 2018-12-31)
	Profit	4,947,000,000 (2018-12-31)
	Cash	6,911,000,000 (2018-12-31)

		* Document for ï¿½About Sectionï¿½:

		Record changed: 2021-02-12

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for Bristol-Myers Squibb (BMS) (Group)

[1] Evotec SE. (12/17/20). "Press Release: Evotec Achieves Key Milestones in Its Collaboration with Bristol Myers Squibb on Targeted Protein Degradation". Hamburg....
[2] Evotec SE. (10/8/20). "Press Release: Evotec Achieves Milestone in Neurodegeneration Collaboration with Bristol Myers Squibb". Hamburg....
[3] BioGeneration Ventures B.V.. (6/24/20). "Press Release: BioGeneration Ventures Closes BGV IV Fund at €105 Million". Naarden....
[4] ADC Therapeutics S.A.. (4/21/20). "Press Release: ADC Therapeutics Appoints Jennifer Creel as Chief Financial Officer". Lausanne....
[5] Medicen Paris Region. (4/20/20). "Press Release: Medicen Paris Region Appoints Jessica Leygues as CEO". Paris....
[6] Cellectis S.A.. (4/13/20). "Press Release: Cellectis Appoints Carrie Brownstein, M.D., as Chief Medical Officer". New York, NY....
[7] Bristol-Myers Squibb Company. (3/18/20). "Press Release: Bristol Myers Squibb Appoints Elizabeth Mily as Executive Vice President, Strategy & Business Development". New York, NY....
[8] Oxford Biomedica plc. (3/18/20). "Press Release: Oxford BioMedica Signs License & Clinical Supply Agreement with Juno Therapeutics, Inc., a Bristol-Myers Squibb Company, for LentiVector Platform for CAR-T and TCR-T Therapeutics". Oxford....
[9] Biocartis Group N.V.. (3/5/20). "Press Release: Biocartis Announces New Immuno-Oncology Project with Bristol-Myers Squibb Aimed at Registration of Idylla MSI test in China". Mechelen....
[10] Voluntis S.A.. (3/3/20). "Press Release: Voluntis and Bristol-Myers Squibb to Co-develop Digital Therapeutics for Oncology". New York, NY & Paris....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]